chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report received from a patient via a company representative concerned multiple patients. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced almost near to death, bed ridden, so sick for more than 15 days, headache, muscle ache, throw up, and diarrhea.The action taken with covid-19 vaccine ad26.cov2.s was not applicable.The outcome of the so sick for more than 15 days, headache, muscle ache, bed ridden, throw up, diarrhea and almost near to death was not reported.This report was non-serious.; Sender's Comments: V0: Medical assessment comment is not required as per standard procedure as case is assessed as non-serious.
I received the vaccine around 9:00am on 1/22/2021, and around 7:30pm, I began running a low grade fever of 99.1 which is pretty high compared to my normal body temperature. I also experienced muscle soreness and chills. After taking Tylenol, the symptoms subsided. Around 3:15am on 1/23/2021, I woke up with a 101.2 degree fever along with more intense muscle soreness, chills, and light-headedness. I felt slightly nauseous and had a headache. I took Tylenol again to lower the fever. When I woke up around 8:00am, the symptoms were gone except for lingering fatigue.
Whole body urticarial rash with 2-4 mm wheals & surrounding flare. Very itchy.
Patient had onset of lower extremity pain, then weakness resulting in non weight bearing status. He had some lower extremity sensory loss, all of his symptoms resolved with IVIG treatment.
COVID-19 virus test positive; COVID-19 virus test positive; This is a spontaneous report from a Pfizer-sponsored program "Pfizer First Connect" from a contactable consumer reporting for himself. A male patient of an unspecified age received the 1st dose of bnt162b2 (BNT162B2), via an unspecified route of administration, on 22Dec2020, at single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced COVID-19 virus test positive on an unspecified date with outcome of unknown. It was reported that the patient was scheduled to get his second dose on 12Jan2021, however between 22Dec2020 and 12Jan2021 the patient experienced the adverse event.  The information on the lot/batch number has been requested.
This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Deviation from the recommended interval between the two doses) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     No Medical History information was reported.No concomitant medication was reported    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Deviation from the recommended interval between the two doses). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Deviation from the recommended interval between the two doses) outcome was unknown. Not Provided    Treatment medication was not provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Patient under 65 received Fluad QIV; Aches; Headache; Fever; This spontaneous case received on 05-Nov-2020 from other health professional (nurse) via Agency (reference number: SEQW20-04839) and concerned a 31-year-old, female patient.   The patient had no relevant medical history. The patient's concomitant medications were not reported.   On 29-Sep-2020, the patient was vaccinated with Fluad Quadrivalent (influenza vaccine, inactivated influenza virus surface antigen (subunit), egg-derived, MF59, dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid) (explicitly coded as 'Inappropriate age at vaccine administration') for influenza prophylaxis. The batch number reported was 286592.   On an unknown date in 2020, an unknown amount of time after receiving Fluad Quadrivalent, the patient experienced fever, aches and headache. The patient was treated with Tylenol (paracetamol).  The outcome of the events was not reported.  The reporter did not provide a causality assessment.  The case was assessed as non-serious.  The case is linked to the cases 202004845, 202006068, 202006069, 202006072, 202006077, 202006080, 202006081, 202006084, 202006085, 202006086, 202006087, 202006089, 202006090, 202006091, 202006092, 202006095, 202006097 and 202006098 (the same reporter).  Company comment: A 31-year-old, female patient was vaccinated with Fluad Quadrivalent. An unknown amount of time after receiving Fluad Quadrivalent, the patient developed pain, pyrexia and headache. With information available, causal role of the suspect vaccine is assessed as possibly related. Product administered to patient of inappropriate age is assessed as not related, per company's conventions.; Sender's Comments: A 31-year-old, female patient was vaccinated with Fluad Quadrivalent. An unknown amount of time after receiving Fluad Quadrivalent, the patient developed pain, pyrexia and headache. With information available, causal role of the suspect vaccine is assessed as possibly related. Product administered to patient of inappropriate age is assessed as not related, per company's conventions.
This spontaneous report as received from a registered nurse refers to an 18 year old female patient. The patient had no pre-existing diagnosed allergies, birth defects or medical conditions. On 12-NOV-2012, 14-JAN-2013 and 03-JUL-2013, the patient was vaccinated with respectively the first, second and third dose of human papillomavirus vaccine (manufacturer unknown) for prophylaxis (lot#, expiry date, dose and route of administration not provided). The patient forgot that she had been vaccinated, reported to a physician that she had not received any of human papillomavirus vaccine, signed consent and on 26-SEP-2017 she was vaccinated with a dose of GARDASIL 9 lot # N015087, expiry date 20-OCT-2019, intramuscularly for prophylaxis. She was not ill during the vaccination. There were no other vaccinations within 4 weeks prior this date. Then she spoke to her mother and returned to tell that she had already completed the series (in the other office). On an unknown date, the patient experienced localized reaction only (not specified after which dose of vaccine). The outcome of  localized reaction was recovered. On an unknown date after the injection (unspecified which injection), the patient experienced hives, which resolved on an unknown date with diphenhydramine. The reporter did not assess causality between the events and suspect therapies.
This spontaneous report as received from a pharmacy technician refers to a 4 year old patient of unknown gender. Patient's concurrent conditions, medical history, concomitant medications, drug reactions and allergies were not reported. On 26-FEB-2018, the patient was vaccinated with improperly stored dose of VARIVAX (lot # N022979, expiry 23-AUG-2019) for prophylaxis. No adverse effect was reported. The VARIVAX temperature excursion occurred on 14-DEC-2017 and 30-DEC-2017. On 14-DEC-2017, the vaccine was exposed to the temperature of 16.9 degree Fahrenheit (F) for 30 minutes. On 30-DEC-2017, the vaccine was exposed to the temperature of 6 degree Fahrenheit (F) to 14 degree F for 30 minutes. It was reported that the event was because of data logger. No product quality complaint was involved. This is one of the several reports received from the same reporter source. Sender's Comments: US-009507513-1802USA001558.
This case was extracted from the VAERS database via a search of QSCAN on 24 February 2009 (reference number 331012). A 45-year-old female patient received an intramuscular injection of FLUZONE (lot number 2755AA) on 22 October 2008. Approximately two hours after vaccination, she experienced fever, chills, seizing chest pain, sore throat, headache, conjunctivitis, muscle aches, and nausea. She presented to the clinic for evaluation; treatment was not reported. All events except conjunctivitis resolved within 12 hours.
This spontaneous report was received from a healthcare professional and refers to a currently 13 months old, male patient. The patient's medical history and concurrent conditions were not reported. On 15-DEC-2015, the patient was vaccinated with an improperly stored dose of VARIVAX lot # L008270 with expiration date 11-MAR-2017 (dose, and route of administration were not provided). No concomitant medications were reported. No adverse effects were reported. This is one of several reports received from the same source. Additional information is not expected as all scheduled follow up information was received.
About 9 hours after receiving vaccine, pt had chills (was shaking) for 30 mins to an hour. She has never had reaction to vaccine before.
Pt vaccinated with DTP 2 hrs later developed diffuse urticaria; Benadryl IM, Decaoton Im given. Hospitalized 24 hrs later with hives/coughing.
1 hour after inject patient complained of chest pain, dizziness, and severe headache- ED was called in to asses- dispatcher advised to give 4 tablets of 81mg aspirin
Pt has muscle soreness at injection site. This soreness is persisting now, a month after the vaccination. Feels like strained muscle in bicep and shoulder, improves during the day but is worse ever morning. No numbness or tingling in the arm. Pt has received flu shots in past without problems.
8/4/11 Grandmother brought child in with localized reaction. Right arm around injection site for VARIVAX approximate size of a baseball, site was red and warm with small bruise. Child reports getting dizzy from time to time since vaccination. Child states "I feel heavy & light". Reports "just not feeling good." Advised grandmother to seek medical attention if symptoms persist or worsen.
Cluster of vesicles at site of VZV administration left thigh. 4 other scabs on trunk and leg.
Rash near injection site.  I noticed it yesterday at about noon. At that time, it was a large red splotch about three inches round. Not raised or itchy. Today it is a red circle in the same area. Slightly raised - not itchy.
received 2 doses of boostrix; This case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a 29-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 57GJ2, expiry date 29th May 2023) for prophylaxis.   Concomitant products included DIPHTHERIA TOXOID + PERTUSSIS TOXOID ACELLULAR + TETANUS TOXOID (BOOSTRIX).   On 24th August 2021, the patient received the 2nd dose of Boostrix. On 24th August 2021, unknown after receiving Boostrix, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.  Additional details were provided as follows: The patient had received 2nd dose of Boostrix additionally, which led to extra dose administered. The reporter consented to follow up via Email.
Within a few minutes after receiving vaccines listed below, patient began to break out in hives and minutes later started to complain of difficulty breathing. On exam, widespread hives and wheezing. Epinephrine 1:1000, 1.5ml given SC. Neb albuterol 0.5ml in 3cc NS, Benadryl (half tsp) PRN. Patient improved rapidly and was observed in clinic for 4-6 hours with no further problems. Discharged with albuterol and Pictone. Medical records states anzphylaxis. msv
HYPOTENSION 7/28/2021 AORTIC ANEURYSM, UNSPECIFIED SITE  ACUTE RESPIRATORY FAILURE 12/9/2021 AORTIC ANEURYSM, UNSPECIFIED SITE  ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/5/2021 AORTIC ANEURYSM, UNSPECIFIED SITE HYPOXIA 11/13/2021 AORTIC ANEURYSM, UNSPECIFIED SITE  HYPOTENSION 7/28/2021 PSOAS MUSCLE ABSCESS  ACUTE RESPIRATORY FAILURE 12/9/2021 PSOAS MUSCLE ABSCESS  ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/5/2021 PSOAS MUSCLE ABSCESS  HYPOXIA 11/13/2021 PSOAS MUSCLE ABSCESS  HYPOTENSION 7/28/2021 ABDOMINAL AORTIC ANEURYSM >=5.5 CM W HX OF ENDOVASCULAR REPAIR  ACUTE RESPIRATORY FAILURE 12/9/2021 ABDOMINAL AORTIC ANEURYSM >=5.5 CM W HX OF ENDOVASCULAR REPAIR  ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/5/2021 ABDOMINAL AORTIC ANEURYSM >=5.5 CM W HX OF ENDOVASCULAR REPAIR HYPOXIA 11/13/2021 ABDOMINAL AORTIC ANEURYSM >=5.5 CM W HX OF ENDOVASCULAR REPAIR  HYPOTENSION 7/28/2021 ABDOMINAL AORTIC ANEURYSM >=5.5 CM W HX OF ENDOVASCULAR REPAIR  ACUTE RESPIRATORY FAILURE 12/9/2021 ABDOMINAL AORTIC ANEURYSM >=5.5 CM W HX OF ENDOVASCULAR REPAIR  ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/5/2021 ABDOMINAL AORTIC ANEURYSM >=5.5 CM W HX OF ENDOVASCULAR REPAIR  HYPOXIA 11/13/2021 ABDOMINAL AORTIC ANEURYSM >=5.5 CM W HX OF ENDOVASCULAR REPAIR  HYPOTENSION 7/28/2021 ATHEROSCLEROSIS OF AORTA  ACUTE RESPIRATORY FAILURE 12/9/2021 ATHEROSCLEROSIS OF AORTA  ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/5/2021 ATHEROSCLEROSIS OF AORTA  HYPOXIA 11/13/2021 ATHEROSCLEROSIS OF AORTA  HYPOTENSION 7/28/2021 NONTRAUMATIC ACUTE KIDNEY INJURY  ACUTE RESPIRATORY FAILURE 12/9/2021 NONTRAUMATIC ACUTE KIDNEY INJURY  ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/5/2021 NONTRAUMATIC ACUTE KIDNEY INJURY  HYPOXIA 11/13/2021 NONTRAUMATIC ACUTE KIDNEY INJURY  HYPOTENSION 7/28/2021 AORTIC ANEURYSM, UNSPECIFIED SITE  ACUTE RESPIRATORY FAILURE 12/9/2021 AORTIC ANEURYSM, UNSPECIFIED SITE  ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/5/2021 AORTIC ANEURYSM, UNSPECIFIED SITE  HYPOXIA 11/13/2021 AORTIC ANEURYSM, UNSPECIFIED SITE  HYPOTENSION 7/28/2021 AORTIC ANEURYSM, UNSPECIFIED SITE  ACUTE RESPIRATORY FAILURE 12/9/2021 AORTIC ANEURYSM, UNSPECIFIED SITE  ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/5/2021 AORTIC ANEURYSM, UNSPECIFIED SITE  HYPOXIA 11/13/2021 AORTIC ANEURYSM, UNSPECIFIED SITE
Had uncontrollable shaking, cold. Fever 101.9. TYLENOL used - sweat through the night.
Employee had generalized rash (2/14)that  evolved(2/17) into hives throughout body and lump sensation in throat with slight DOB.
loose stools; awoke feeling chilled; Sore Arm; Fever 100.8; Nausea; Body Aches; Vomiting; Was tired that evening; This spontaneous case was reported by a pharmacist and describes the occurrence of DIARRHOEA (loose stools), FEELING COLD (awoke feeling chilled), PAIN IN EXTREMITY (Sore Arm), PYREXIA (Fever 100.8) and NAUSEA (Nausea) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included GERD since 2007. Concomitant products included OMEPRAZOLE for GERD.    On 19-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FATIGUE (Was tired that evening). On 20-Jan-2021, the patient experienced DIARRHOEA (loose stools), FEELING COLD (awoke feeling chilled), PAIN IN EXTREMITY (Sore Arm), PYREXIA (Fever 100.8), NAUSEA (Nausea), MYALGIA (Body Aches) and VOMITING (Vomiting). The patient was treated with PARACETAMOL (TYLENOL) (oral) at a dose of 1 g and IBUPROFEN (oral) at a dose of 600 mcg. On 20-Jan-2021, FATIGUE (Was tired that evening) had resolved. On 21-Jan-2021, DIARRHOEA (loose stools), FEELING COLD (awoke feeling chilled), PYREXIA (Fever 100.8), NAUSEA (Nausea), MYALGIA (Body Aches) and VOMITING (Vomiting) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore Arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Jan-2021, Body temperature: 100.4 (High) 100.4 degree Fahrenheit and 101 (High) 101 degree Fahrenheit.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable   This case was linked to MOD-2021-237097 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 11-Jun-2021: Follow-up information received and added patient race and ethnic group, medical history, concomitant medication and new events.
Raised, hard, hot area near injection about 1.5 inches. Arm irritated in the area of injection. Raised area hot, painful and slightly itchy. On evening of 3/30/13 migraine headache. On 3/31 runny nose and still painful irritated arm. On 4/1 the raised area is slightly reduced, now rash appears as a double rash.  Outer rash is about 6 inches in diameter. Inner area about 2 inches.  Still irritated on 4/1 and swollen.
Severe pain on my right arm and tiny bit of my shoulder sharp pains that lasts usually about 10 minutes. Wednesday and progressively got worse, Thursday, Friday and Saturday the pain increased; Severe pain on my right arm and tiny bit of my shoulder sharp pains that lasts usually about 10 minutes. Wednesday and progressively got worse, Thursday, Friday and Saturday the pain increased; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (BNT162B2 reported as PFIZER COVID-19 Vaccine; unknown lot number and expiration date), via an unspecified route of administration left arm on 19Jan2021 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that "I had the Pfizer vaccine last Tuesday [unspecified date] and on my left arm and after 2 days I had the vaccine [unspecified date], I am having a severe pain on my right arm only, my right arm and tiny bit of my shoulder on right arm and the pain is steady but then I have sharp, very, very sharp pains that lasts usually about 10 minutes and then it goes away." The patient further clarified that "I had it Tuesday [unspecified date] and I had a little bit of pain in my right arm on Wednesday and progressively got worse, Thursday and Friday and Saturday [unspecified date] the pain increased. Thursday was less pain, Friday and Saturday the pain on the right arm has increased instead of decrease." The patient inquired if this was normal reaction to have just pain on the other side. The outcome of the event was not recovered.  The following information on the batch/lot number has been requested.
Itching et swelling began shortly after admin. of VARIVAX. Cont. to swell. Returned to clinic on 8/29/15. Area red, warm, and swollen. Area 17cm x 14cm. Prescribed short course prednisone, BENADRYL, and DOMEBORO SOLN. compresses.
pt recvd vax & was crying for more than 3 hrs (lasted 5-6 hrs); apap given;
Patient received 2nd Shingrix on 3/7/21 at our pharmacy. Had no adverse events reported from 1st dose. Patient called pharmacy 3/14/21 to report that starting around 3/10/21 she experienced a few welts on her body. She says that they are similar to mosquito bites and mildly itch. She has one on the arm that the vaccination was given in and a few on her knee. She denies that they could be mosquito or other bug bites. States that welt on left arm is in general area of where vaccine was given (I did not see welts personally as she called us to describe them). Welts mildly itch but are not hard, blistering, oozing, or bleeding. Denies any other symptoms. I advised her to use hydrocortisone 1% cream for itching and to continue to monitor herself and to reach out to her PCP if they do not resolve or worsen.
Information has been received from a registered nurse (R.N.) concerning a 64 year old female with thyroid disorder and antihistamine allergy who was vaccinated intramuscularly with her first 0.5 ml dose of PNEUMOVAX 23 on 16-OCT-2008 and has developed injection site pain, swelling and tenderness that has persisted since the injection. The patient also complained of a sinus infection that began the day after the vaccine and has now resolved. Concomitant therapy included thyroid medication and vitamin. The patient sought medical attention by visiting the physician's office. No additional information is available. Follow up information was received from a registered nurse (R.N.) concerning the female patient with no pre-existing allergies, birth defects, or medical conditions who was vaccinated intramuscularly in the right deltoid with the first dose of PNEUMOVAX 23 (lot#661039/0248X) on 16-OCT-2008 and developed redness and swelling at the injection site. No relevant diagnostic tests or laboratory data was collected. No outcome was reported. Additional information has been requested.
After receiving the vaccines listed below in #13, my son seemed more agitated and less restful, i.e. difficult to get to bed at night or nap. He has currently been diagnosed with symbolic language disorder, ADHD, oppositional defiance. He is currently undergoing speech therapy, behavior therapy, music therapy, early childhood at school, in addition to taking supplements.  9/12/08 Reviewed PCP medical & vaccination records of 8/12/2006-8/21/2008. FINAL DX: Language disorder Records reveal patient experienced speech concerns on day of vaccination using approx 3 words.  Also had patchy eczema at that time.  Ear, uro & allergy consults done prior to vaccination date.  PE tubes placed.  Currently being evaluated for ASD/PDD.
I only had the Moderna vaccine on 10/12/23. I have gotten Moderna on all vaccines and boosters. I've had a negative reaction to each but not as bad as the first one or this last one. Within a few hours of the injection, I began feeling weak, lightheaded, and symptoms progressed into a headache and muscle pain, and weakness. The headache was strange like my brain was floating in my skull. I had to lie down to relieve some of the head issues. Over the coming days these symptoms listed above continued and increased in strength. I also had chills, vomiting, and nausea. Most of the symptoms continued for 9 days. It's been 5 days since the main symptoms stopped but I still have times of lightheadedness and dizziness. I have an appointment with my doctor the end of next week.
Red rash/bumps, itchy starting 2 weeks after vaccination. Only in the area of vaccination. Appeared after being in the sun outside. Patient has been using hydrocortisone cream. Recommended trying Benadryl as well as calling her physician tomorrow about the rash.
Felt faint, shortness of breath was kept extra 30 min.  In days after the shot I went from feeling like I was in a fog and expected fever. Into hypersensitivity to light and sounds which caused me not to be able to leave my home until June 2021.
In the morning of 11/8/2017 (3 days after the event), pt called to report that he had rash on her left arm. Pt reported heat and rash at the injection site (her deltoid) at night 11/5/17. Pt came to pharmacy on 11/8/2017 to have a consultation about the rash. The pharmacist on-duty noticed that she had a dark-red bruise on her left arm as big as the size of a quarter. A lighter red rash was also seen surrounding the bruise and spreading. There was no life threatening signs and symptoms were observed. The pharmacist recommended TYLENOL 500mg Q4H, cetirizine 10 mg daily, and hydrocortisone cream Q4H. According to record, PREVNAR 13 was suspected as the cause of the adverse reaction since she had only 1 inject at that site. 11/11/2017 pharmacist followed up with the patient again, Patient reported that she had to go to urgent care and that she was taking antibiotic. She said that her rash got better, but still sick.